Incyte Corporation

Incyte Corporation

World Rank (Aug-2026)
1044
Market Cap (Aug-2026)
24.356 Billion USD
World Rank (Jan-05-2024)
1,185
Market Cap (Jan-05-2024)
14.923 Billion USD
World Rank (Jul-30-2023)
1,265
Market Cap (Jul-30-2023)
14.075 Billion USD
World Rank (Jan-07-2022)
1,253
Market Cap (Jan-07-2022)
16.167 Billion USD
World Rank (Jan-01-2021)
950
Market Cap (Jan-01-2021)
19.048 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 494
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
Top Bio Pharmaceutical Companies in USA
Nasdaq / NYSE Code
INCY
CEO
Herve Hoppenot
Employee Count
2,324
Employee Count as of Date
As on 2022
Headquarters City/State
Delaware
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
5,141 Million USD
Annual Operating Income in USD
1,515 Million USD
Annual Net Income in USD
1,287 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
6,958 Million USD
Total Liabilities in USD
1,790 Million USD
Total Equity in USD
5,167 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
Pharmaceutical
HealthCare Products
Company Website
Incyte Corporation - Pharmaceutical Company
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Facebook
Facebook
Company Profile

Incyte Corporation is a Bio-Pharmaceutical company with headquarters is in Delaware, USA.

As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

As on 2022, Incyte Corporation has 2,324 employees.

Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

Incyte Corporation annual net income generated for period ending Dec-2022 was 340 million USD.

Annual Results Summary

INCYTE CORPORATION - Annual Results Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Dec-20233,6953,440649597
Dec-20223,3943,187591340
Dec-20212,9862,856585948
Dec-20202,6672,535-264-296
Dec-20192,1592,045402447
Dec-20181,8821,788129109
Dec-20171,5361,457-243-313
Balance Sheet Summary

INCYTE CORPORATION - Balance Sheet Summary - in Million USD

Year Ending:Total AssetsTotal LiabilitiesTotal Equity
Dec-20225,8401,4704,370
Dec-20214,9331,1633,770
Dec-20203,5619492,611
Dec-20193,4268282,598
Dec-20182,6457201,926
Dec-20172,3016721,630
Founded Year
1991
Stock Category
S&P 500
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Commercial Physical & Biological Resarch

Share